Robert S. Blissett
AuthID: R-00K-9EE
1
TITLE: Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US
AUTHORS: Fanikos, John; Goldstein, Joshua N.; Lovelace, Belinda; Beaubrun, Anne C.; Blissett, Robert S.; Aragao, Filipa;
PUBLISHED: 2022, SOURCE: JOURNAL OF MEDICAL ECONOMICS, VOLUME: 25, ISSUE: 1
AUTHORS: Fanikos, John; Goldstein, Joshua N.; Lovelace, Belinda; Beaubrun, Anne C.; Blissett, Robert S.; Aragao, Filipa;
PUBLISHED: 2022, SOURCE: JOURNAL OF MEDICAL ECONOMICS, VOLUME: 25, ISSUE: 1
INDEXED IN: 
WOS
WOS2
TITLE: Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment
AUTHORS: Fagiuoli, S; Ruggeri, M; Aragao, F; Blissett, R;
PUBLISHED: 2021, SOURCE: GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, VOLUME: 8
AUTHORS: Fagiuoli, S; Ruggeri, M; Aragao, F; Blissett, R;
PUBLISHED: 2021, SOURCE: GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, VOLUME: 8
INDEXED IN: 
Scopus WOS
Scopus WOS